INS and Impaired glucose tolerance: The withdrawal of CsA or TAC was associated with a significant fall of insulin sensitivity and with a defect in the compensatory beta-cell response.The switch to SRL was associated with a 30% increase of incidence of impaired glucose tolerance and with four patients’ developing PTDM. SRL increased peripheral insulin resistance and impaired pancreatic beta-cell response.